This reprogramming raised effector molecules production such as CD25, IFN‐γ, and TNF and dramatically enhanced anticancer efficacy of antigen‐specific CTLs and ROR1‐targeting chimeric antigen receptor T cells in murine melanoma and PC models.454. The gene discussed is TNF; the disease is pachyonychia congenita.